GPR84 regulates pulmonary inflammation by modulating neutrophil functions.

Authors:
Wang SW; Zhang Q; Lu D; Fang YC; Yan XC and 7 more

Journal:
Acta Pharmacol Sin

Publication Year: 2023

DOI:
10.1038/s41401-023-01080-z

PMCID:
PMC10072043

PMID:
37016043

Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests YMZ, employee of Burgeon Therapeutics Co. Ltd, participated in the synthesis of BGT-004. All authors declare that they have no competing interests."

Evidence found in paper:

"This work was supported by the National Natural Science Foundation of China (82121005, 81730099, 22077132, and 82030109), Shanghai Science and Technology Commission (20S11903200, TM202101H005, and 19ZR1411600), and Youth Innovation Promotion Association of the Chinese Academy of Sciences grants (2020283)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025